Multus

Multus is a biotechnology company that provides lab-grown meat alternatives using cellular agriculture technology. The company uses cells from livestock animals to cultivate meat products without animal slaughter, providing sustainable alternatives to conventionally produced meat. Multus technology focuses on developing the growth media and bioprocessing infrastructure needed to make cultured meat production commercially viable, addressing one of the key cost barriers in cellular agriculture. The company approach enables the production of real animal meat with significantly reduced environmental impact, eliminating the need for animal farming while providing the same nutritional and sensory qualities as conventional meat. Founded in 2019 and headquartered in London, United Kingdom, Multus has raised approximately $9.3 million in Series A funding from investors including Ukri, Mandi Ventures, SOSV, SynBioVen, and Asahi Kasei.